Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Cappuzzo

Showing results (171-180 of 275) with videos related to

Pageof 28
Sort By:
Oncotarget|February 8, 2019
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancerManolo D'Arcangelo, Armida D'Incecco, Claudia Ligorio, et al.
Journal of Clinical Pathology|December 2, 2011
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring studyAndrea Sartore-Bianchi, Steffen Fieuws, Silvio Veronese, et al.
Cancer|July 2, 2003
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational StudyFederico Cappuzzo, Giovanni Selvaggi, Vanesa Gregorc, et al.
Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patientsFederico Cappuzzo, Marileila Varella-Garcia, Hisayuki Shigematsu, et al.
International Journal of Molecular Sciences|December 11, 2022
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA ExplorationEriseld Krasniqi, Frauke Goeman, Claudio Pulito, et al.
Clinical Lung Cancer|January 25, 2025
Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung AdenocarcinomaRiccardo Tajè, Vincenzo Ambrogi, Federico Tacconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancerFrancesco Graziano, Nadia Galluccio, Paola Lorenzini, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
JTO Clinical and Research Reports|April 6, 2026
Oncological Outcomes of Complete Versus Limited Thymectomy in Early Stage Thymic Epithelial Tumors: A Systematic Review and Individual Patient Data Meta-AnalysisRiccardo Tajè, Filippo Tommaso Gallina, Gabriele Alessandrini, et al.
Pageof 28

Showing results (171-180 of 275) with videos related to

Sort By:
Pageof 28
Oncotarget|February 8, 2019
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancerManolo D'Arcangelo, Armida D'Incecco, Claudia Ligorio, et al.
Journal of Clinical Pathology|December 2, 2011
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring studyAndrea Sartore-Bianchi, Steffen Fieuws, Silvio Veronese, et al.
Cancer|July 2, 2003
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational StudyFederico Cappuzzo, Giovanni Selvaggi, Vanesa Gregorc, et al.
Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patientsFederico Cappuzzo, Marileila Varella-Garcia, Hisayuki Shigematsu, et al.
International Journal of Molecular Sciences|December 11, 2022
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA ExplorationEriseld Krasniqi, Frauke Goeman, Claudio Pulito, et al.
Clinical Lung Cancer|January 25, 2025
Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung AdenocarcinomaRiccardo Tajè, Vincenzo Ambrogi, Federico Tacconi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancerFrancesco Graziano, Nadia Galluccio, Paola Lorenzini, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
JTO Clinical and Research Reports|April 6, 2026
Oncological Outcomes of Complete Versus Limited Thymectomy in Early Stage Thymic Epithelial Tumors: A Systematic Review and Individual Patient Data Meta-AnalysisRiccardo Tajè, Filippo Tommaso Gallina, Gabriele Alessandrini, et al.
Pageof 28